New York State Psychiatric Institute
New York, 10032, United States
NCT Number: NCT03766971
Cannabis smokers who also smoke tobacco cigarettes have markedly higher rates of cannabis relapse relative to those who do not use tobacco. There is a clear need to develop and evaluate interventions for dual tobacco and cannabis users. The investigators of this study have previously shown that the co-use of tobacco cigarettes contributes to the maintenance of daily cannabis use, and that age of cigarette onset is a critical predictor of treatment outcome. Short-term tobacco cessation may suffice in altering cannabis relapse rates in later-onset cigarette smokers, while a longer period of tobacco cessation may be needed for earlier-onset smokers. In the current study, a human laboratory model will be utilized to determine whether cannabis relapse varies as a function of tobacco cessation duration and age of tobacco use onset.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Phase 2
New York, 10032, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will be randomly assigned to 7 days of tobacco cessation.
Other names: Early onset
Participants will be randomly assigned to 21 days of tobacco cessation.
Other names: Late onset
Participants will receive cannabis.
Time frame: During 9-day inpatient phase
Number of cannabis cigarettes participant chooses to smoke.
New York State Psychiatric Institute
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07489443
Behavior, Cannabis Use
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT06609109
Behavior, Cannabis Use
Baltimore, Maryland, United States
View Trial DetailsNCT04812613
Behavior, Cannabis Use
Ottawa, Ontario, Canada
View Trial DetailsNCT06609083
Behavior, Cannabis Use
Baltimore, Maryland, United States
View Trial Details